Contact
Please use this form to send email to PR contact of this press release:
Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients
TO:
Please use this form to send email to PR contact of this press release:
Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients
TO: